Compare OZK & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OZK | AMRX |
|---|---|---|
| Founded | 1903 | 2002 |
| Country | United States | United States |
| Employees | 3351 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.8B |
| IPO Year | N/A | 2018 |
| Metric | OZK | AMRX |
|---|---|---|
| Price | $51.77 | $17.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $55.00 | $15.60 |
| AVG Volume (30 Days) | 1.2M | ★ 1.9M |
| Earning Date | 04-21-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | N/A |
| Revenue This Year | $12.84 | $4.48 |
| Revenue Next Year | $6.32 | $7.13 |
| P/E Ratio | ★ $8.01 | $97.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.37 | $8.21 |
| 52 Week High | $53.66 | $19.26 |
| Indicator | OZK | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.13 | 61.48 |
| Support Level | $49.03 | $12.46 |
| Resistance Level | $53.14 | $19.26 |
| Average True Range (ATR) | 0.94 | 0.56 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 80.72 | 63.64 |
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides banking services, including checking, savings, money market, time deposits, and individual retirement accounts, as well as loan services, such as real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services, it also provides trust and wealth management, financial planning, online banking, and other related services.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.